SLAM
NUVB icon

Swiss Life Asset Management’s Nuvation Bio NUVB Stock Holding History

Swiss Life Asset Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$103K Buy
18,129
+2,367
+15% +$11.6K ﹤0.01% 1587
2026
Q1 		$67.6K Buy
15,762
+4,508
+40% +$25.1K ﹤0.01% 1476
2025
Q4 		$101K Buy
11,254
+652
+6% +$4.04K ﹤0.01% 1347
2025
Q3 		$39.2K Buy
+10,602
New +$28.9K ﹤0.01% 1179

Other funds holding NUVB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM

Swiss Life Asset Management's NUVB Position: Q2 2026 in Review

Swiss Life Asset Management increased its Nuvation Bio (NUVB) stake by 15% in Q2 2026, buying an estimated $11.6K and bringing the position to 18,129 shares worth $103K. The position accounts for ﹤0.01% of the portfolio, ranked #1587.

Swiss Life Asset Management first reported a position in NUVB in Q3 2025 and has held it in 4 quarters since. 131 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Swiss Life Asset Management held 18,129 shares of Nuvation Bio worth $103K as of Q2 2026.
  • Swiss Life Asset Management bought 2,367 Nuvation Bio shares in Q2 2026, an estimated $11.6K.
  • Nuvation Bio made up ﹤0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #1587 holding.
  • Swiss Life Asset Management first reported a position in Nuvation Bio in Q3 2025 and has held it in 4 quarters since.
  • 131 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.